Search

… Perspectives Call on Disease Education and Endpoints in Usher Syndrome LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 16, …

… Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, …

… Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2 LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. …

… to Present Results from Phase 1/2 Trial of QR-421a for Usher Syndrome LEIDEN, Netherlands & CAMBRIDGE, Mass., March 17, …

… First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2 LEIDEN, Netherlands and CAMBRIDGE, Mass., …

… Presentation on QR-421a Program in Ophthalmology at Usher Syndrome Coalition Conference in July LEIDEN, Netherlands and … announced an upcoming presentation at the 11 th Annual Usher Connections Conference.  Presentation at USH2019 A …

… ProQR’s Drug Candidate QRX-421 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA …